April 3, 2020

March 31, 2020

March 27, 2020

March 20, 2020

The quarterly use and expenditure pattern reports provide prescription drug use and expenditure information for the most prescribed individual drugs and therapeutic drug classes.

March 17, 2020

March 11, 2020

March 2, 2020

Our drug shortage notification process is available for pharmacy staff to notify HHSC about potential drug shortages that impact prescribing choice and pharmacy claim processing

February 26, 2020

February 21, 2020

February 14, 2020

February 7, 2020

The Texas Drug Utilization Review Board met recently to make recommendations about clinical prior authorizations and the preferred drug list.

January 23, 2020

January 17, 2020

VDP will modify the Austedo prior authorization criteria on March 3. The criteria are included within the existing Vesicular Monoamine Transporter 2 (VMAT2) Inhibitors criteria guide. The class includes Austedo, Xenazine and Ingrezza.